Pediatric Hematology and Oncology
- Assistant Professor, Department of Pediatrics
EDWARD CHAN MD
BRAIN CANCER (BRAIN TUMOR)
RESEARCH TRIALS (CLINICAL TRIALS)
AFFINITY HEALTH PLAN
CIGNA GREAT WEST HEALTHCARE
EMPIRE BLUE CHOICE HMO
EMPIRE BLUE CHOICE OTHER PLANS
EMPIRE BLUE CHOICE PPO
FIDELIS CARE NEW YORK
ISLAND GROUP ADMINISTRATION
NEIGHBORHOOD HEALTH PLAN
SUFFOLK HEALTH PLAN
UNITED EMPIRE PLAN (NYSHIP)
UNITED OXFORD FREEDOM PLAN
US FAMILY HEALTH PLAN
VYTRA (except SMART START)
Education & Training
- State University of New York at Buffalo, NY
- Pediatrics, Children's Hospital of Buffalo, NY
Pediatric Hematology/Oncology, Cincinnati Children's Hospital Medical Center, OH
Academic & Other
- Academic Rank:
- Assistant Professor
- Teaching Activity:
- Undergraduate, graduate and medical students; pediatric residents
- Year Appointed at
(1)2009-14 American Cancer Society Mentored Research Scholar Grant
(2)2012-14 Clinical Research Award, TRO Grant Program
(3)2010-11 Catacosinos Cancer Translational Researcher Award
(4)2009-11 NIH/NCI-R21 Award
(5)2007-09 NIH Pediatric Research LRP Award
(6)2006-08 Clinical Scholar Research Award, Stony Brook SOM
(7)2005-07 Carol M. Baldwin Breast Cancer Research Award
(8)2003-04 American Cancer Society Institutional Research Grant
(9)2002-04 CCHMC-NICHD Special Research Fellowship
(10)07/03 Scholar-In-Training Award, American Association for Cancer Research
(11)05/03 Young Investigator Travel Award, Society for Pediatric Research
(12)Letters of Commendation, SUNY at Buffalo
Children's Oncology Group
- Clinical Practice Began:
- Cantonese, Chinese
3 EDMUND D PELLEGRINO RD,
(1)Hu Y, Ahmed T, Zaslav AL, Golightly M, Spitzer SG, Raetz E, Chan EL. Lymphoproliferative disorder that resembles heptosplenic lymphoma during maintenance treatment for T-cell acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013 Jan 9. [Epub ahead of print].
(2)Sarangi SN, Golightly M, Weber J, Chan EL. A family with Bolzano-type Bernard-Soulier syndrome carries a benign A1939T MYH9 mutation. Platelets. 2013;24(1):81-4.
(3)Keller J, Shroyer KR, Batajoo SK, Zhao HL, Dong LM, Hayman MJ, Chan EL. Combination of phosphorylated and truncated EGFR correlates with higher tumor and nodal stage in head and neck cancer. Cancer Investigation 2010 Dec;28(10):1054-62.
(4)Chan E, Nimnual AS. Deregulation of the cell cycle by breast tumor kinase (Brk). Int J Cancer 2010 Dec 1;127(11):2723-31.
(5)Chan EL, Gruppo RA, Harris RE, Emery KH, Gelfand MJ and Collins MH. Favorable Histology, MYCN Amplified, 4S Neonatal Neuroblastoma. Pediatric Blood and Cancer April 2007;48(4):479-82.
(6)Chan EL, Peace BE, Collins MH, Toney-Earley K and Waltz SE. The Ron tyrosine kinase receptor regulates papilloma growth and malignant conversion in a murine model of skin carcinogenesis. Oncogene 2005;24(3):479-88.
(7)Chan EL, Peace BE, Collins MH, Toney-Earley K and Waltz SE. Homozygous K5Cre transgenic mice have pronounced wavy hair and associated with accelerated malignant progression in a murine model of skin carcinogenesis. Molecular Carcinogenesis Jan 2007;46(1):49-59.
(8)Hess KA, Waltz SE, Chan EL and Degen SJF. Receptor tyrosine kinase Ron is expressed in mouse reproductive tissues during embryo implantation and is important in trophoblast cell function. Biology of Reproduction 2003;68:1267-75.
Dr. Chan is a board certified pediatric hematologist/oncologist whose laboratory investigates tyrosine kinase receptors as biomarkers and therapeutic targets. Our long term goal is to develop personalized molecular target therapy for cancers.